News & Resources

Clinical Immersion Programs (HOLI) – Part 2

Clinical immersion programs are elective courses that offer continuing education for various life science teams as well as practicing clinicians. These programs are traditionally held in a clinical setting and meant to train attendees on a range of topics, including disease state education, competitive landscape, treatment patterns, and expert perspectives in the management of cancer patients. All these things inform diagnosis and treatment decision-making and ultimately support better-quality care. This is the second post in a series on clinical immersion programs. Find the first article here.

Course content is fully customizable on the basis of attendee needs, and clinical immersion programs are consistently ranked as top educational training tools for the life science industry. They are often developed in partnership with centers of excellence or community practices. Most healthcare organizations and life science companies rely on these programs to keep their employees up-to-date and to bridge gaps in knowledge, as well as to fulfill continuing education requirements.

Clinical Immersion Programs for Pharma
Clinical immersion programs are a necessity for pharmaceutical companies. While some employees have a medical background, others have limited experience in a clinical setting. Immersion courses in pharma are usually geared toward drug discovery and development, including both the scientific and regulatory aspects of these activities.

Players in the pharmaceutical space need to understand the clinical context of their products: they should be able to share knowledge about a drug’s delivery mechanism, mode of action, or potential adverse effects. Sales teams, for example, often need to articulate their understanding of a product in conversations with physicians. The ability to communicate nuances helps them stand out.

Aptitude Health, which specializes in oncology and hematology, has delivered clinical immersion programs to internal pharma staff, including sales teams and medical science liaisons. While it is critical for a pharma company to develop a savvy sales team, other needs for immersion training in the pharma environment include onboarding faculty with new network capabilities and informing them of new regulatory practices.

Digital Versions Are the New “Normal”
During the COVID-19 pandemic, in-person sessions were abandoned in favor of digital solutions. Virtual training platforms indeed proved to be a cost-effective alternative and supported increased accessibility for attendees, who could join a session from anywhere. In fact, this new “normal” has demonstrated additional benefits.

Virtual capabilities allow more flexibility in scheduling training sessions, without hurdles like reserving a space, organizing/buying additional resources for a classroom, and accommodating a host of logistic needs. Utilizing digital platforms, a company can plan and implement a clinical immersion program on the fly, say to prepare staff for an upcoming product launch or to share brand-new data following a conference or meeting.

Digital courses are formatted according to the goals of the client and may include interactive presentations, case study workshops, competitive simulations, role-play exercises, and panel discussions. To get a more realistic picture of how clinical immersion programs can be utilized for a pharma audience, let’s look at some examples from Aptitude Health’s Hematology Oncology Learning Institute (HOLI).

Case Study Example 1: Clinical Immersion Program
Let’s consider an example scenario of a successful clinical immersion program. Aptitude Health was asked to design a digital training course for a pharma client who had acquired a poly(ADP-ribose) polymerase (PARP) inhibitor from another company. The goal of the HOLI program was to educate the client’s global medical teams on monotherapy and combination therapy of PARP inhibitors in prostate cancer.

The HOLI clinical immersion program was structured as 2 half-day sessions that ran for 3 hours each day. The first day focused on monotherapy indications of PARP inhibitors; the second day centered on combination therapy. The program featured presentations by 3 globally renowned experts, along with interactive patient case workshop rotations and attendee question-and-answer sessions.

Case Study Example 2: Integrated Delivery Networks
In a second example, we’ll examine a HOLI virtual training program on integrated delivery networks (IDNs). The client commissioned this course to train their new payor-focused team on IDNs. A small but vital team of around a dozen market access employees participated in 2 half-day sessions, including didactic lectures and panel discussions on health and hospital systems, specialty pharmacy, and payor-related topics. Program faculty included PharmDs and administrators from major IDNs.

For this program, Aptitude Health partnered with Excelera to prepare the course content, answering questions like, What are the benefits and challenges of a large healthcare system compared with independent hospitals or private practices? What are the various physician provider models in a hospital system? And what is the role of IDNs in cancer care delivery? In fact, the discussion around IDNs as they influence the practice of oncology was a particular focus of this HOLI program.

Partner With Agencies That Have Program Experience
As training programs increasingly migrate to virtual platforms, they offer an easier way to schedule educational seminars and improve program access to teams. This makes partnering with an experienced agency even more valuable. In today’s landscape, life science companies need to seek longer-term partnerships with agencies that have plenty of experience in organizing digital clinical immersion programs.

Not only should agencies demonstrate expertise in designing and executing clinical programs for virtual platforms, but they should also show a deep commitment to understanding their client’s business. In the pharma space, this means demonstrating familiarity with nuanced processes like pharmacovigilance, adverse events monitoring, and compliance.

An agency with project management prowess is not enough. Subject matter expertise is crucial and can make or break a good pharma-agency relationship. An agency should further deliver access to a host of external experts like global key opinion leaders and health system networks. Backed by unparalleled access to industry experts and market-driving physicians, Aptitude Health is a valuable strategic partner for companies in the oncology market.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.